Figure 2 4 GLP-1RA reduced the risk of stroke in T2D patients clinically As a new type of hypoglycemic drug, GLP-RAs are currently mainly used in clinical practice to evaluate the prognosis of various complications in T2D patients, such as stroke, kidney injury, fatty liver, and cardiovascular disease (42, 43)
Liposomal Glutathione Yeast Extract (90% Glutathione) 42.86% [Yeast Extract (India), Lecithin, Citric Acid], Pullulan, Lemon Juice Powder (Lemon/USA), Vitamin C, Hyaluronic Acid, Pectin, Enzymatically Modified Stevia (Sweetener), Natural Flavor (Natural Lemon Lime Flavor), Glycerin, Polysorbate 80, Beta-Cyclodextrin, Other Processed Edible Oils and Fats (Malaysia), Modified Starch, Prolastin (Elastin), Anhydrous Citric Acid, Milk Thistle Extract Powder, Carotene, Low Molecular Weight Fish Collagen, Milk Ceramide, Vitamin E 50% Mixture (dl-alpha-Tocopheryl Acetate, Modified Starch, Glucose Syrup Powder, Silicon Dioxide), Biotin
Neurology 84 , 22472257 (2015)
But here's the scientific reality: that's a massive oversimplification
The output is a mass spectrum, a graph of ion intensity versus m/z